Pharmaceuticals & Biotech.
Pharmaceuticals & Biotech.
SECTOR | 25 Jun 2016
Phillip Capital
INR/EUR, and INR/USD) could have some minor impact on Indian pharma. GBP/EUR have depreciatedby8.9%/2.6%againsttheINRduetoBrexit,whiletheINRhasdepreciated1.2% againsttheUSD.AdversecurrencyfluctuationsintheGBPandEURarealmostneutralisedby...
More from Pharmaceuticals & Biotech.
Recommended